{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_edea23", "batch_size": 250, "batch_pos": 204, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "Segment does not contain a high-potency verb, potent metaphor, superlative + negative noun, or critical alert phrase.", "method": "llm_batch", "batch_id": "batch_2_e79317", "batch_size": 246, "batch_pos": 200, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "No moderate verb paired with explicit scale/impact information.", "method": "llm_batch", "batch_id": "batch_3_771b4a", "batch_size": 234, "batch_pos": 193, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "No loaded rhetorical question designed to imply alarm.", "method": "llm_batch", "batch_id": "batch_4_182d7f", "batch_size": 233, "batch_pos": 192, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Source is official, but reports uncertainty about manufacturing capacity, not an explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_19ef0a", "batch_size": 228, "batch_pos": 189, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment contains 'too early to tell how many' which is not a minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_9882cf", "batch_size": 225, "batch_pos": 186, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_27b557", "batch_size": 222, "batch_pos": 183, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes a limitation on manufacturing capability ('too early to tell how many doses... will be able to manufacture') without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_aa1765", "batch_size": 163, "batch_pos": 134, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
